Reuters USA

US payrolls show labor market remains strong but wages rises cool

NEW YORK (Reuters) – The U.S. economy maintained a strong pace of job growth in December, with the unemployment rate falling to 3.5%, but higher borrowing costs as the Federal Reserve fights inflation could see the labor market momentum slowing significantly by mid-year. Nonfarm payrolls increased 223,000 last month, the Labor Department said in its …

US payrolls show labor market remains strong but wages rises cool Read More »

Now able to sell abortion pill, U.S. pharmacies weigh if they should

By Ahmed Aboulenein, Gabriella Borter and Michael Erman (Reuters) – Pharmacies across the United States are weighing whether to sell mifepristone, a pill used in medication abortions, following the Food and Drug Administration’s announcement earlier this week that they can now do so. What they decide is primarily based on where they are located given …

Now able to sell abortion pill, U.S. pharmacies weigh if they should Read More »

What is the U.S. ‘Title 42’ immigration policy and why is it expanding?

By Ted Hesson and Mica Rosenberg WASHINGTON/NEW YORK (Reuters) -The United States announced on Thursday it will extend COVID-19 pandemic-era restrictions, known as Title 42, to expel migrants from Nicaragua, Cuba and Haiti caught crossing the U.S.-Mexico border back to Mexico, a move would block more nationalities from seeking asylum in the United States. At …

What is the U.S. ‘Title 42’ immigration policy and why is it expanding? Read More »

U.S. House brawl over McCarthy raises worries about Republican governance

By David Morgan WASHINGTON (Reuters) – The bare-knuckle political fight among Republicans over Kevin McCarthy’s run for speaker of the U.S. House of Representatives could signal trouble ahead when lawmakers need to agree on bigger issues, like addressing the nation’s debt ceiling. Republicans captured a thin House majority in November’s midterm elections, breaking the hold …

U.S. House brawl over McCarthy raises worries about Republican governance Read More »

U.S. FDA grants priority review to Roche’s bispecific antibody Glofitamab

ZURICH (Reuters) – Roche announced on Friday the U.S. Food and Drug Administration has granted priority review to the Swiss pharmaceutical company’s bispecific antibody Glofitamab. Glofitamab is intended for patients with relapsed or refractory large b-cell lymphoma. The FDA is expected to make a decision on approval of the cancer immunotherapy by July 1, 2023. …

U.S. FDA grants priority review to Roche’s bispecific antibody Glofitamab Read More »